ADI-212
Topline/data readout1H27 & 2H27
Stage: Not stated
Public float: $50,500,000 · as of · SEC filing
Clinical Data Expected 1H27 & 2H27
8-K · Filed · Last checked
Source details
Alert me · Calendar: same stage and window-end month (2027-12)
Adicet Bio (ACET) pipeline and stated timing
Name in SEC filings: Adicet Bio, Inc.
Pipeline at a glance
Source: ORION, orionbiotechai.com/company/ACET, data as of Oct 13, 2026
https://www.orionbiotechai.com/company/ACET
ADI-212 · Topline/data readout · 1H27 & 2H27
SEC sources last checked .
Programs and stated timing
○ Quote matched to filing (not yet reviewed by founder) · ✓ Checked by founder.
Matched
How this date was described over time
Company periods and sentences are quoted as written. A matching disclosure uses the SEC filing date for the same program and event type. As of .
| Program / event | Stated period and SEC wording | Disclosure in stated period |
|---|---|---|
| ADI-212Clinical results | 1H27 & 2H27“Clinical Data Expected 1H27 & 2H27” Filed · EX-99.1 | Period not started The stated period has not started yet, so there is nothing to compare. |
| ADI-212Clinical results | second half of 2026“Subject to regulatory clearance to proceed with a clinical trial, we expect to report initial clinical data from this program in the second half of 2026.” Filed · 10-Q | Not compared ORION has no confirmed start and end dates for this wording, so it is not compared with filings. |
| ADI-212Clinical results | second half of 2026“Subject to regulatory clearance to proceed with a clinical trial, we expect to report initial clinical data from this program in the second half of 2026.” Filed · 10-Q | Not compared ORION has no confirmed start and end dates for this wording, so it is not compared with filings. |
“Not compared” means ORION has not matched this wording against a complete set of SEC filings for its period. It says nothing either way about whether a matching filing exists. Wording without exact dates is not given calendar dates.
Watch ACET
Request another SEC timing statement
Suggest an SEC timing statement to add for ACET. You can include the original filing link in your note. The founder reads each request by hand.
Or email ORION.
Reading these records
- First stated window
- The timing wording in the earliest company statement located within the sources checked, quoted as written (for example “2H 2026”). An earlier statement may exist outside those sources.
- Disclosure date
- The date of the filing or company release that disclosed the readout. “None found” means no such disclosure was located in the sources checked. SEC filings were searched through the “SEC filings searched through” date shown.
- 1H, 2H, 1Q–4Q
- First or second half, or first to fourth quarter, of the year named, as the company wrote it. Equivalent notations are compared together; the original wording stays visible.
- SEC original
- The filing as published on the SEC EDGAR system. “Company original” is the release on the company's own investor site.
- Status
- One of seven labels set by founder review of the original filings. Definitions: Methodology.
See ACET in the calendar · Review labels and methodology
Topline results are the main summary results of a clinical trial, released before the full data.1H means January–June and 2H means July–December of the stated year, unless the company uses a different fiscal year.